Fig. 8 Quininib (1) and ace-quininib (2) inhibit angiogenesis in zebrafish. (A–D) Live fluorescence images of ISVs of zebrafish embryos (24 hpf) treated for 20 h with (A) DMSO 0.1 % v/v; (B) montelukast (12.5 μM), (C) quininib (1) (12.5 μM), (D) ace-quininib (2) (12.5 μM). (E) Quantification of the average length of ISV of zebrafish embryos. Embryos were treated with DMSO (0.1 % v/v), montelukast (12.5 μM), quininib (1) (12.5 μM), and ace-quininib (2) (12.5 μM). N = 10. One-way analysis of variance (ANOVA) was performed for statistical analysis. Error bars represent mean ± SEM, ∗∗∗∗p < 0.0001. N = 10.
Image
Figure Caption
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Eur. J. Med. Chem.